Roivant Sciences Ltd. (ROIV)

The settlement helped Roivant post net income of $355.7 million for the quarter, compared with a loss of $252.4 million a year earlier. Earnings per share came in at $0.28, compared to consensus estimates of a loss of $0.34, according to fiscal.ai data. Retail sentiment for ROIV on Stocktwits ...

Roivant Sciences reported its fourth-quarter earnings for fiscal year 2026, showcasing a robust cash position and strategic advancements in its product pipeline. Despite missing earnings per share (EPS) expectations, with an actual EPS of -0.73 compared to a forecast of -0.6, the company remains foc…

Before this Q4 surprise, the most ... in earnings by 2029, which shows how widely views can differ on the same pipeline story and why it helps to compare your own expectations with several competing narratives. Explore 4 other fair value estimates on Roivant Sciences - why the stock might be worth .…

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the 10 Stocks With Insane Returns Right Now. Roivant Sciences grew its share prices by 14.89 percent on Wednesday to close at $32.41 apiece, as investors took heart from its swing to profitability in the fourth quarter of fiscal year 2026, while ...

(NASDAQ:ROIV – Get Free Report) gapped up before the market opened on Wednesday following a better than expected earnings announcement. The stock had previously closed at $28.21, but opened at $29.60. Roivant Sciences shares last traded at $31.7910, with a volume of 2,079,051 shares traded.